compliance issues reimbursing glp-1 weight loss treatments multiple states FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of State Employee Health Insurance Ends

If symptoms feel severe, persistent, or worrying, please contact a qualified healthcare professional

The legal and health risks of obtaining these compounds through grey-market channels are therefore considerable

The incomplete digestion causes the proteins to create microtears in the intestinal lining of ALL who consume gluten

doi: 10.3389/fphar.2025.1706936 Received 16 September 2025 Revised 16 December 2025 Accepted 16 December 2025 Published 09 January 2026 Volume 16 - 2025 Edited by Lucas Cezar Pinheiro, Federal University of Santa Catarina, Brazil Reviewed by Mithun Rudrapal, Vignans Foundation for Science, Technology and Research, India Linxiaoxi Ma, Fudan University, China Updates Copyright 2026 Yang, Li, Lu, Xu, Guo and He

Am J Hum Genet 64 , 15051510 (1999)